Seeing Is Believing
Currently out of the existing stock ratings of Liana Moussatos, 184 are a BUY (89.76%), 20 are a HOLD (9.76%), 1 are a SELL (0.49%).
Analyst Liana Moussatos, currently employed at WEDBUSH, carries an average stock price target met ratio of 41.65% that have a potential upside of 46.92% achieved within 306 days.
Liana Moussatos’s has documented 402 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CLSD, Clearside Biomedical at 13-Mar-2024.
Analyst best performing recommendations are on GRAY (GRAYBUG VISION).
The best stock recommendation documented was for GRAY (GRAYBUG VISION) at 3/9/2021. The price target of $8 was fulfilled within 2 days with a profit of $0.8 (11.11%) receiving and performance score of 55.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$18
4 years 6 months 26 days ago
(01-Sep-2020)
3/3 (100%)
$3.19 (21.54%)
78
Hold
$60
4 years 6 months 24 days ago
(31-Aug-2020)
0/19 (0%)
$41.31 (221.03%)
Hold
$34.5
$0.01 (0.03%)
$66
4 years 6 months 24 days ago
(31-Aug-2020)
1/8 (12.5%)
$0.28 (0.82%)
39
Hold
$34.5
$0.01 (0.03%)
$14
4 years 6 months 24 days ago
(31-Aug-2020)
7/7 (100%)
$0.28 (0.82%)
105
Hold
$35
$0.51 (1.48%)
$24
4 years 6 months 24 days ago
(31-Aug-2020)
7/17 (41.18%)
$0.78 (2.28%)
376
What Year was the first public recommendation made by Liana Moussatos?